Filament Health terminates proposed business combination with Jupiter Acquisition

Filament Health Corp (NEO:FH, OTCQB:FLHLF) has terminated its prior agreement with Jupiter Acquisition Corporation (NASDAQ: JAQC), 1427702 B.C. Ltd., and Filament Merger Sub LLC for a proposed business combination. The termination is a result of material changes required to meet Nasdaq listing requirements, impacting the terms of the combination and senior secured convertible notes financing by Helena Global Investment Opportunities. Without pursuing the combination, the Note Financing will not proceed.